Sponsored The international Cannabis scene dazzles aficionados with its variety of UK cannabis strains. Connoisseurs remain on a quest, aiming to discover cannabis strains that offer...
Adam Kavalier PhD, scientific director of Anthera Pharmaceuticals, explores what we know about medical cannabis in the treatment of PTSD.
Cristelle Santos, consultant toxicologist at Broughton Group, shares her experiences as a toxicologist in the CBD sector.
Michael Sassano, CEO and founder of SOMAÍ Pharmaceuticals, explores the latest developments in Ukraine.
Almost six years since the law change, children still struggle to access a consistent supply of medicine in the UK, writes Matt Hughes, Medcan Family Foundation.
Libby Clarke, managing consultant for Toxicology at Broughton, explores how CBD companies can optimise their testing strategies.
An expert explains everything you need to know about the entourage effect.
Michael Sassano CEO and founder of SOMAÍ Pharmaceuticals, explains how to find the right dose.
James Leavesley and Brady Green, head grower at Dalgety, discuss what insights the UK can glean from more advanced markets.
Dave Barton, co-founder and creative director at cannabis content agency, thermidor<, explores the challenges brands face in marketing medical cannabis and wonders whether any of them...
